Co-Authors
This is a "connection" page, showing publications co-authored by Yunqing Qiu and Jifang Sheng.
Connection Strength
1.102
-
Decreased B Cells on Admission Associated With Prolonged Viral RNA Shedding From the Respiratory Tract in Coronavirus Disease 2019: A Case-Control Study. J Infect Dis. 2020 07 06; 222(3):367-371.
Score: 0.223
-
[Pharmaceutical care for severe and critically ill patients with COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(2):158-169.
Score: 0.221
-
Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19. Front Immunol. 2021; 12:631226.
Score: 0.058
-
The Artificial-Liver Blood-Purification System Can Effectively Improve Hypercytokinemia for COVID-19. Front Immunol. 2020; 11:586073.
Score: 0.058
-
Virus strain from a mild COVID-19 patient in Hangzhou represents a new trend in SARS-CoV-2 evolution potentially related to Furin cleavage site. Emerg Microbes Infect. 2020 Dec; 9(1):1474-1488.
Score: 0.057
-
Analysis of Epidemiological and Clinical Features in Older Patients With Coronavirus Disease 2019 (COVID-19) Outside Wuhan. Clin Infect Dis. 2020 07 28; 71(15):740-747.
Score: 0.056
-
Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study. Am J Gastroenterol. 2020 07; 115(7):1075-1083.
Score: 0.056
-
A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia. Engineering (Beijing). 2020 Oct; 6(10):1122-1129.
Score: 0.056
-
[Management of COVID-19: the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25; 49(2):147-157.
Score: 0.055
-
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020 04 21; 369:m1443.
Score: 0.055
-
Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020 06; 69(6):1002-1009.
Score: 0.055
-
[Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21; 49(1):147-157.
Score: 0.054
-
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020 Feb 19; 368:m606.
Score: 0.054
-
Open-label phase I clinical trial of Ad5-EBOV in Africans in China. Hum Vaccin Immunother. 2017 09 02; 13(9):2078-2085.
Score: 0.045